Gardasil Vaccination for Recurrent Laryngeal Papillomatosis in Adult Men
- 8 April 2016
- journal article
- Published by Elsevier BV in Journal of Voice
- Vol. 31 (1), 104-106
- https://doi.org/10.1016/j.jvoice.2016.01.008
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Assessment of Human Papilloma Virus Infection in Adult Laryngeal Papilloma Using a Screening TestJournal of Voice, 2013
- Immunogenicity of the Quadrivalent Human Papillomavirus (Type 6/11/16/18) Vaccine in Males 16 to 26 Years OldClinical and Vaccine Immunology, 2012
- Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trialThe Lancet, 2009
- Rekurrierende respiratorische PapillomatoseDeutsche Medizinische Wochenschrift (1946), 2009
- Juvenile Larynxpapillomatose – Impfung mit dem polyvalenten Spaltimpfstoff Gardasil®Laryngo-Rhino-Otologie, 2008
- Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trialThe Lancet Oncology, 2006
- Optimization and Validation of a Multiplexed Luminex Assay To Quantify Antibodies to Neutralizing Epitopes on Human Papillomaviruses 6, 11, 16, and 18Clinical and Vaccine Immunology, 2005
- Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective studyThe Lancet, 1999
- Detection and Typing of Multiple Genital Human Papillomaviruses by DNA Amplification with Consensus PrimersJapanese Journal of Cancer Research, 1991
- Demonstration of human papillomavirus types 6 and 11 in juvenile laryngeal papillomatosis by in‐situ DNA hybridizationThe Journal of Pathology, 1987